210 related articles for article (PubMed ID: 10680416)
1. Ocular toxicity of systemic medications: a case series.
To TQ; Townsend JC
Optometry; 2000 Jan; 71(1):29-39. PubMed ID: 10680416
[TBL] [Abstract][Full Text] [Related]
2. Ocular side effects of selected systemic drugs.
Jaanus SD
Optom Clin; 1992; 2(4):73-96. PubMed ID: 1363080
[TBL] [Abstract][Full Text] [Related]
3. Drug induced ocular lipoidosis.
Clemett RS; MacKintosh HT
Trans Ophthalmol Soc N Z; 1982; 34():52-8. PubMed ID: 6979822
[No Abstract] [Full Text] [Related]
4. Amiodarone-induced ultrastructural changes in human eyes.
Ghosh M; McCulloch C
Can J Ophthalmol; 1984 Jun; 19(4):178-86. PubMed ID: 6744103
[TBL] [Abstract][Full Text] [Related]
5. Drugs affecting the eye.
Taylor F
Aust Fam Physician; 1985 Aug; 14(8):744-5. PubMed ID: 2864912
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced ocular disorders.
Li J; Tripathi RC; Tripathi BJ
Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
[TBL] [Abstract][Full Text] [Related]
7. Ocular Adverse Effects of Amiodarone: A Systematic Review of Case Reports.
Alshehri M; Joury A
Optom Vis Sci; 2020 Jul; 97(7):536-542. PubMed ID: 32697562
[TBL] [Abstract][Full Text] [Related]
8. Ocular and cutaneous effects of chronic phenothiazine therapy.
Bond WS; Yee GC
Am J Hosp Pharm; 1980 Jan; 37(1):74-8. PubMed ID: 6102438
[No Abstract] [Full Text] [Related]
9. [Iatrogenic pathology of the eye].
Watillon M
Rev Med Liege; 1986 May; 41(9):361-76. PubMed ID: 3523671
[No Abstract] [Full Text] [Related]
10. Ocular effects in long-term amiodarone therapy.
Ingram DV
Am Heart J; 1983 Oct; 106(4 Pt 2):902-5. PubMed ID: 6613837
[TBL] [Abstract][Full Text] [Related]
11. Optic neuritis with concurrent etanercept and isoniazid therapy.
Noguera-Pons R; Borrás-Blasco J; Romero-Crespo I; Antón-Torres R; Navarro-Ruiz A; González-Ferrandez JA
Ann Pharmacother; 2005 Dec; 39(12):2131-5. PubMed ID: 16264061
[TBL] [Abstract][Full Text] [Related]
12. Ocular complications of oral contraceptives.
Wood JR
Ophthalmic Semin; 1977; 2(4):371-402. PubMed ID: 306593
[TBL] [Abstract][Full Text] [Related]
13. [Drug-induced eye lesions in the aged].
Slezak H
Aktuelle Gerontol; 1983 Sep; 13(5):187-90. PubMed ID: 6139035
[TBL] [Abstract][Full Text] [Related]
14. Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy.
Castells DD; Teitelbaum BA; Tresley DJ
Optometry; 2002 Feb; 73(2):113-21. PubMed ID: 12365708
[TBL] [Abstract][Full Text] [Related]
15. [Control of serious visual functions during thioridazine therapy].
Balík J; Trnková M; Rudlová B
Cesk Oftalmol; 1977 Sep; 33(5):343-7. PubMed ID: 922907
[No Abstract] [Full Text] [Related]
16. Miotic drugs: a review of ocular, visual, and systemic complications.
Rengstorff R; Royston M
Am J Optom Physiol Opt; 1976 Feb; 53(2):70-80. PubMed ID: 1084694
[TBL] [Abstract][Full Text] [Related]
17. Visual functions and adverse ocular effects in patients with amiodarone medication.
Ikäheimo K; Kettunen R; Mäntyjärvi M
Acta Ophthalmol Scand; 2002 Feb; 80(1):59-63. PubMed ID: 11906306
[TBL] [Abstract][Full Text] [Related]
18. Ocular toxicity in low-dose tamoxifen: a prospective study.
Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
[TBL] [Abstract][Full Text] [Related]
19. Ocular complications of topical, peri-ocular, and systemic corticosteroids.
Carnahan MC; Goldstein DA
Curr Opin Ophthalmol; 2000 Dec; 11(6):478-83. PubMed ID: 11141645
[TBL] [Abstract][Full Text] [Related]
20. Ocular adverse effects of neuropsychiatric agents. Incidence and management.
Oshika T
Drug Saf; 1995 Apr; 12(4):256-63. PubMed ID: 7646824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
